Clinical outcomes that are associated with the various
|
|
- Paulina Long
- 5 years ago
- Views:
Transcription
1 Clinical Course Associated with Vascular Access Type in a National Cohort of Adolescents Who Receive Hemodialysis: Findings from the Clinical Performance Measures and US Renal Data System Projects Jeffrey J. Fadrowski,* Wenke Hwang, Diane L. Frankenfield, Barbara A. Fivush,* Alicia M. Neu,* and Susan L. Furth* *Department of Pediatrics, Johns Hopkins University School of Medicine, Centers for Medicare & Medicaid Services, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland; and Department of Public Health, Wake Forest University School of Medicine, Winston-Salem, North Carolina Limited research has described clinical outcomes that are associated with the type of vascular access in pediatric patients who receive maintenance hemodialysis. This retrospective cohort study examined prevalent pediatric patients who were aged 12 to <18 yr and identified in the 2000 ESRD Clinical Performance Measures Project as receiving in-center hemodialysis. Vascular access type as of December 31, 1999, was identified. These patients were linked with 1 yr of data (January 1, 2000, through December 31, 2000) from US Renal Data System standard analytic files that allow for the comparison of rates of hospitalizations and access complications by access type. Of the 418 patients who met inclusion criteria, the mean age was 15.6 yr, 53% were male, 49% were white, the mean time on dialysis was 22 mo, and 42% had a structural/urologic cause of ESRD; 42% of patients had an arteriovenous graft or fistula, and 58% had a vascular catheter. Patients with a vascular catheter as compared with those with a graft or fistula had the following adjusted relative risks (95% confidence interval): 1.84 (1.38 to 2.44) for hospitalization for any cause, 4.74 (2.02 to 11.14) for hospitalization as a result of infection, and 2.72 (2.00 to 3.69) for a complication of vascular access. Vascular catheters are the predominant access type in adolescent patients who receive maintenance hemodialysis and are associated with significantly more hospitalizations and complications. Clin J Am Soc Nephrol 1: , doi: /CJN Clinical outcomes that are associated with the various types of vascular access in adults who have ESRD and receive maintenance hemodialysis have been well described. Studies have demonstrated repeatedly that arteriovenous fistulas (AVF) have increased longevity and decreased complication rates in adults as compared with arteriovenous grafts (AVG) and vascular catheters (1 14). This evidence has contributed to AVF s being the preferred hemodialysis access type in adults. This has been emphasized by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) Clinical Practice Guidelines for vascular access and the Centers for Medicare & Medicaid Services (CMS) Fistula First, the National Vascular Access Improvement Initiative (15,16). Received February 14, Accepted June 14, Published online ahead of print. Publication date available at The interpretation and reporting of the data herein are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the US government or the Centers for Medicare & Medicaid Services. Address correspondence to: Dr. Jeffrey J. Fadrowski, Park 335, 600 N. Wolfe Street, Baltimore, MD Phone: ; Fax: ; jfadrow1@jhmi.edu A significant number of pediatric patients receive hemodialysis as renal replacement therapy. Of the 2271 prevalent dialysis patients aged 0 to 19 yr in the US Renal Data System (USRDS) reported in 2003, approximately 60% received hemodialysis. In the 15- to 19-yr age group, 70% received hemodialysis. Among incident pediatric patients who were aged 0 to 19 yr and initiated dialysis from 1993 to 2003, the percentage of patients who were on hemodialysis increased from 54% in 1993 to 59% in 1998 and 62% in 2003 (17). Vascular catheters are the predominant form of vascular access in the pediatric hemodialysis population. The 2004 ESRD Clinical Performance Measures (CPM) Project reported vascular access type in a national cohort of 678 pediatric patients who were receiving in-center hemodialysis as of December 31, Twenty-seven percent were dialyzed with an AVF, 12% with an AVG, and 60% with a catheter. Examination of vascular type in adolescent patients during the past 5 yr of ESRD CPM Projects reveals a steady increase in the use of vascular catheters (18,19). Limited research has examined clinical outcomes that are associated with the various access types in children. The majority of the studies published are retrospective and center or region specific (20 27). Limited data and pediatric-specific challenges regarding vascular access complicate the determination of the applicability and the relevance of the adult-based Copyright 2006 by the American Society of Nephrology ISSN: /
2 988 Clinical Journal of the American Society of Nephrology Clin J Am Soc Nephrol 1: , 2006 NKF-K/DOQI Clinical Practice Guidelines to the pediatric population; forthcoming NKF-K/DOQI Pediatric Vascular Access Clinical Practice Guidelines will address such issues. To further the understanding of vascular access patterns and associated clinical complications in the pediatric population, this study examines a national cohort of adolescent hemodialysis patients. Materials and Methods Design, Setting, and Participants This is a retrospective cohort study using merged data from two national databases in the United States: CMS s ESRD CPM Project and the USRDS, which collect clinical and demographic information, as well as data regarding hospitalization and survival of patients who receive hemodialysis. CMS began routinely assessing the quality of care that is provided to adult ESRD patients in 1994, and this data collection now is known as the ESRD CPM Project. Details of the methods of data collection for the ESRD CPM Project have been reported elsewhere (18,28). The USRDS maintains data on all incident and prevalent ESRD patients in the United States, including demographic, laboratory, insurance, and medical data. The USRDS collects additional data on dialysis claims and information on treatment history and hospitalization events (17). A limited data set was created by linking the USRDS patient identification number in the USRDS standard analytic file with ESRD CPM data collected in 2000 (for October through December 1999). At the time of this analysis, the USRDS standard analytic file was updated through January These data were examined to describe clinical outcomes, including hospitalizations, procedures, and mortality associated with the various types of vascular access in the pediatric age group. The 2000 ESRD CPM Project year was the first year that data collection was expanded to include all adolescent ( 12 to 18 yr of age) patients who were receiving in-center hemodialysis in the United States as of December 31, 1999 (corresponding with ESRD CPM Project Year 2000). From this cohort, patients were included in this study when their vascular access type was indicated within the ESRD CPM Project and they were identified in the USRDS. Variables of Interest and Methods The independent variable of interest was type of vascular access. These data were obtained from the ESRD CPM patient data file, which described the type of vascular access in use on or between October 1, 1999, and December 31, 1999, the period of data collection for the 2000 ESRD CPM Project year. Access type choices that were included on the 2000 ESRD CPM data collection form were AVF, synthetic AVG, bovine graft, vascular catheter, other, or unknown. For patients who met inclusion criteria, 12 mo of USRDS inpatient hospitalization and outpatient records were available for examination. A timeline was created for the year of follow-up, to account for possible switches in access type and facilitate a time-at-risk analysis. The beginning of the observation period was January 1, 2000, and the end was December 31, Patients were censored for kidney transplant and death. Patients were reassigned to a new access type according to the following rules: (1) When AVF creation was listed in the procedure codes, the patient was reassigned to AVF 12 wk after the procedure; (2) when AVG creation was listed in the procedure codes, the patient was reassigned to AVG 3 wk after the procedure; and (3) when a vascular catheter was listed in the procedure codes, the patient was reassigned to a vascular catheter on the day of the procedure. To assess the validity of reported access type in the ESRD CPM Project, we compared the access type indicated for patients who were present in both the 2000 and the 2001 ESRD CPM study, and this also was correlated with hospitalization and procedure claims in the USRDS. Approximately 10% of patients who were categorized as having an AVF or an AVG in the ESRD CPM 2000 Project year subsequently were categorized in the opposite category in the ESRD CPM 2001 Project year, with no procedure codes to support such a switch. For example, a patient with an AVF in the ESRD CPM 2000 Project year was listed as having an AVG in the ESRD CPM 2001 Project year, with no supporting or confirming evidence in the USRDS data file for this switch. For access types in question (graft versus fistula), USRDS procedure records for the year before January 2000 were examined in an attempt for clarification but with little success. Given that the ESRD CPM data collection forms and the administrative data that are used by the USRDS to create the standard analytic data files commonly are completed by administrative and dialysis staff (nurses or social workers) who likely are not assessing the patient s access regularly, potential for significant misclassification of subcutaneous access types (AVG versus AVF) existed, and our exploratory analyses supported this. Therefore, we chose to collapse the categories of AVF and AVG into a single category, graft/fistula (hereafter referred to as permanent access ). The patient data file from the ESRD CPM Project provided relevant demographic and clinical variables, including age, gender, body size, race, ethnicity, assigned cause of ESRD, date of first dialysis treatment, serum albumin, hemoglobin, and single-pool Kt/V (spkt/v; Daugirdas II method). Underlying causes of ESRD were stratified into the following categories: Congenital/urologic, glomerulonephritis, focal segmental glomerulosclerosis, systemic lupus erythematosus, and other. For serum albumin, hemoglobin, and spkt/v, up to three values were available from data collection during the study period of October, November, and December 1999; an average was taken of these values. For the purpose of regression analyses, covariates were dichotomized as follows: Race, black versus nonblack; dialysis vintage, 6 moversus greater 6 mo; mean hemoglobin, 11 versus 11 g/dl; mean serum albumin, 3.5/3.2 versus 3.5/3.2 g/dl (bromcresol green/bromcresol purple laboratory methods). Dependent variables included all-cause hospitalization, infectionrelated hospitalization, and access-related complications. Hospitalizations were assigned as infection related when the International Classification of Diseases, Ninth Revision code 038.xx (septicemia) or (bacteremia) was listed as either the principal or the secondary diagnosis in the USRDS inpatient claims file. The following inpatient or hospital outpatient procedures were identified within the USRDS standard analytic files to aid in the classification of vascular access, censoring, and determination of an accessrelated complication: Transplant of kidney, revision of vascular procedure, revision/removal of arteriovenous shunt for renal dialysis, other revision of vascular procedure, arteriovenostomy for renal dialysis, insertion/replacement of vessel to vessel cannula, venous catheterization for renal dialysis, and thrombectomy/embolectomy. Complications of vascular access were determined as follows: (1) Thrombectomy/embolectomy of any access type and (2) vascular catheter placed in a patient with a permanent access and considered as a complication of a permanent access. In addition, single procedures that were 7 d apart were considered as separate complications, multiple procedures within the same 7-d period were considered one complication, and vascular catheters that were placed at the time of a kidney transplant were not considered a complication of vascular access or included in the analysis. Statistical Analyses The crude incidence rates of all-cause hospitalization, infectionrelated hospitalization, and access complications were calculated by
3 Clin J Am Soc Nephrol 1: , 2006 Vascular Access Outcomes in Adolescents 989 dividing the number of events by person-year at risk according to access type. Incidence rate ratios and 95% confidence intervals (CI) then were determined. The relative risks for the above outcomes by access type, adjusting for clinical characteristics, were obtained by multiple regression modeling using general estimating equations with robust variance estimation. In addition, sensitivity analyses were performed according to the following algorithm. The USRDS payer history file was examined for each patient to determine whether any potential gaps in Medicare coverage were present. Relative risks then were determined using the same multiple regression modeling as the original analysis but on two restricted population samples: One model excluded any patient with a potential gap in Medicare coverage during the year of follow-up, and one model excluded patients with a gap in coverage of 60 d. All analyses were performed using SAS version 9 (SAS Institute, Cary, NC). Results A total of 433 prevalent adolescent patients who were receiving hemodialysis were identified in the 2000 ESRD CPM Project Year. Of this cohort, 418 patients had the type of vascular access identified in the ESRD CPM Project and were identified in the USRDS and therefore were included in subsequent analyses. As of December 31, 1999, 175 (42%) patients had a vascular catheter and 243 (58%) had a permanent access. Patient characteristics are presented in Table 1. Patients had a mean age of 15.6 yr (SD 1.6); 53% were male, 49% were white, 22% were of Hispanic ethnicity, and 42% had a congenital/urologic cause for their ESRD. The mean dialysis vintage was 22 mo (SD 30). The mean hemoglobin was 11.0 g/dl (1.6), the mean serum albumin was 3.85 g/dl (0.53)/3.61 g/dl (0.52; bromcresol green/bromcresol purple methods), and the mean spkt/v was 1.49 (0.46). When patients were stratified by their type of vascular access, patients with a vascular catheter, as compared with those with a permanent access, were significantly more likely to be younger, to be female, and to have been receiving hemodialysis for a shorter period of time. Patients with a vascular catheter also had a significantly lower hemoglobin and serum albumin as compared with those with a permanent access and were significantly more likely to have a spkt/v 1.2. There was no significant difference in body mass index z score categories, race, ethnicity, cause of ESRD, or occurrence of kidney transplantation by vascular access type. Figure 1 describes patterns in vascular access during the 1 yr of follow-up. The majority (86%) of patients had no change in their vascular access type during the course of follow-up. Eight (2% of total cohort) patients with a catheter switched to a permanent access. Forty-eight (11% of total cohort) patients with a permanent access switched to a catheter. Three patients, all starting the follow-up period with a catheter, had multiple access switches. Of the total sample, 54 (13%) patients received kidney transplantation in Of the patients who received a transplant, 28 (52%) had a vascular catheter and 26 (48%) had a permanent access. Patients who received a transplant had been receiving dialysis for 20 mo (SD 22.5) on average, those with a catheter for 19 mo (SD 27.4), and those with a permanent access for 20 mo (16). Patients with vascular catheters had 1.62 all-cause hospitalizations per person-year at risk, compared with 0.91 hospitalizations in patients with a permanent access (Table 2). The rate of hospitalization for infections was significantly higher in patients with a vascular catheter (0.16 per person-year), compared with those with a permanent access (0.03). The complication Table 1. Patient characteristics, 2000 ESRD CPM Project Year a Characteristic Total Population (n 418) Catheter (n 175) Stratified Population Permanent Access (n 243) P Mean age (yr SD ) 15.6 (1.6) 15.4 (1.6) 15.7 (1.5) Male (%) White (%) Hispanic ethnicity (%) Congenital/urologic disease as cause of ESRD (%) Dialysis vintage (mo SD ) 22 (30) 14.7 (26) 26.8 (32) Mean hemoglobin (g/dl SD ) 11.0 (1.6) 10.6 (1.6) 11.3 (1.4) Mean hemoglobin 11.0 g/dl (%) Mean serum albumin 3.5/3.2 g/dl (%) b Mean spkt/v (SD) 1.5 (0.5) 1.4 (0.5) 1.5 (0.4) Mean spkt/v 1.2 (%) BMI z score categories (%) to Received transplant during year of follow-up (%) a BMI, body mass index; CPM, Clinical Performance Measures; spkt/v, single-pool Kt/V. b Bromcresol green/bromcresol purple laboratory method.
4 990 Clinical Journal of the American Society of Nephrology Clin J Am Soc Nephrol 1: , 2006 Figure 1. Vascular access during 1-yr follow-up period (N 418). rate of a vascular catheter, 1.23 per person-year, was more than double that for a permanent access, 0.54 per person-year. Adjustment for age, gender, race, dialysis vintage, hemoglobin, and albumin (Table 3) provided relative risk estimates that were similar to the crude rate ratios. Sensitivity analyses that were based on the algorithm described did not significantly change the point estimates or CI. For example, the population designated as having complete Medicare coverage during the follow-up period (n 366) had the following relative risks (95% CI), comparing vascular catheters with a permanent access: All-cause hospitalization 1.88 (1.39 to 2.56), infection-related hospitalization 5.50 (2.21 to 13.72), and; complication of access 2.94 (2.13 to 4.05). Discussion Caregivers of pediatric patients who receive hemodialysis likely concur that providing dialysis access to the pediatric population is a time-consuming and frustrating challenge (22). The complication and hospitalization rates that are associated with vascular access and that were observed in this analysis support this statement. This challenge is compounded by the fact that decisions related to the placement and management of vascular access in children carry a lifelong impact. The high rate of renal transplantation in children supports the modus operandi that dialysis is a bridge to transplantation. However, with current management, the vast majority of these children ultimately will return to dialysis at least once in their lifetime. Analysis of United Network for Organ Sharing data from 1987 to 1996 projected graft half-lives of 7 yr for the adolescent age group (13 to 21 yr of age), 11 yr for children (3 to 12 yr of age), and 18 yr in those who are younger than 2 yr (29,30). Data regarding outcomes in the pediatric population exist but have been sparse. Regarding access longevity, Lumsden et al. (22) retrospectively examined hemodialysis access in 24 children. Of 15 AVF, one third failed to mature, and the mean functional patency was mo. Of 21 AVG (polytetrafluoroethylene), the mean functional patency was mo; thrombectomy was performed in 25 cases; and eight graft infections occurred, seven of which resulted in graft loss. Gradman et al. (21) examined 47 consecutive children (mean age 14.6 yr) in whom AVF were constructed. Primary patency at 1 and 2 yr was 100 and 96%, respectively. Three accesses had thromboses, and of these, two were salvaged. No infections were reported. Brittinger et al. (20) reported 20 yr of experience with various types of AVF and AVG in all age groups. Complicationfree functioning of AVF after 12 mo ranged from 57 to 100% for the various age groups and fistula types and from 50 to 100% for AVG. Sheth et al. (24) examined the survival of permanent vascular access in 34 pediatric patients with ESRD. Of 24 AVF, eight (33%) had primary failure. Of the functioning AVF, the 1- and 3-yr patency rates were 74 and 59%, respectively. Of 28 AVG, the 1- and 3-yr patency rates were 96 and 69%, respectively. Thrombosis, stenosis, and infection occurred significantly more frequently in AVG. A 20-yr retrospective study was performed by Ramage et al. (23) A total of 304 access procedures were performed on 114 pediatric patients. Primary failure occurred in 25 of 107 AVF placed. Considering only first-access procedures, the median survival of AVF was 3.1 yr. Of the 182 vascular catheters, the median survival was 0.6 yr. Of possible complications, infections led to access loss in 30% of those with a catheter and 3% of those with an AVF, and thrombosis led to access loss in 54% of those with catheter and 71% of those with AVF. Microsurgical techniques for the placement of AVG and AVF have resulted in improved long-term access survival. Patent and functional AVF in 60% of pediatric patients have been reported at 4 yr of follow-up (31 34). Goldstein et al. (26) examined the survival of 22 cuffed catheters. The 1-yr survival was 27%, with infection and kinking being the most common reasons for removal. Finally, to examine the clinical outcomes of urea clearance, anemia, and serum albumin concentration, Chand et al. (25) prospectively followed 140 pediatric patients during a 2-yr period. A trend toward better urea clearance, higher hemoglobin, and higher albumin was observed in patients with a permanent access compared with those with a catheter. In this study, having a vascular catheter for hemodialysis access was independently associated with an almost two-fold increase in hospitalization, an almost five-fold increase in hospitalization as a result of infection, and an almost three-fold increase in complications of access. Patients with vascular catheters also were more likely to have lower hemoglobin, serum albumin, and spkt/v values. Although this study examines the largest cohort of pediatric hemodialysis patients assembled, it has limitations. USRDS data are generated from administrative billing data; therefore, the possibility of misclassification exists for hospitalizations and procedures by access type. This misclassification bias, however, likely would bias toward a lower estimate of risk than reported. The collapse of the AVF and AVG access categories into the single permanent access category limits comparison of these two groups. However, preliminary analysis of these data found that as compared with AVF, there was not an increased risk for infection-related hospitalization in patients with an AVG (odds ratio 1.2; 95% CI 0.3 to 3.9). In the same analysis, patients with a vascular catheter were 4.5 times more likely to have an infection-related hospitalization as compared with those with an AVF. Pediatric-specific issues related to vascular access must be acknowledged. Patient body size and the availability of vascular surgeons who are skilled and willing to create such accesses in the pediatric population limit options in particular cases.
5 Clin J Am Soc Nephrol 1: , 2006 Vascular Access Outcomes in Adolescents 991 Table 2. Crude incidence rates and rate ratios for outcomes associated with vascular access type in adolescent patients who receive hemodialysis a Outcome Catheter Permanent Access Rate Ratio b 95% CI Hospitalization, all-cause to 2.15 Hospitalization, infection-related to Access complication to 2.90 a Denominator: Person-years. CI, confidence interval. b Comparing catheter to permanent access. Table 3. RR (catheter versus permanent access) of dialysis outcomes in adolescent patients who received hemodialysis a Parameter Hospitalization, All-Cause Hospitalization, Infection-Related Access Complication RR b 95% CI RR 95% CI RR 95% CI Vascular catheter versus permanent access 1.84 d 1.38 to d 2.02 to d 2.00 to 3.69 Age, per year to to to 1.20 Male versus female to to d 1.04 to 2.05 Black versus nonblack to to to 1.76 Dialysis vintage, 6 versus 6 mo to to d 1.11 to 2.35 Mean hemoglobin 11 versus 11 g/dl to to to 1.20 Mean serum albumin 3.5/3.2 versus 3.5/3.2 g/dl c to to to 1.88 a Relative risks (RR) and CI were obtained from general estimating equation regression modeling. b Adjusted for all other variables in table. c Bromcresol green/bromcresol purple laboratory method. d P However, as has been proved in the adult population with ESRD, AVF are associated with less morbidity in the pediatric population. It is likely that most pediatric nephrologists have already extrapolated evidence regarding improved clinical outcomes that are associated with AVF in the adult ESRD population to the pediatric population, yet vascular catheters continue to be the predominant form of vascular access, and there is no evidence that catheter use has decreased during at least the past 5 yr. Future study needs to place emphasis on the barriers to the creation and maintenance of AVF in the pediatric hemodialysis population. With this information, pediatric-specific vascular access guidelines can be formulated so that pediatric nephrologists will be well informed about their current vascular access choices, and their patients will be well positioned for a lifetime of managing chronic kidney disease. Acknowledgments This work was supported by National Institutes of Health grant R21-DK to S.L.F. J.J.F. was supported by the American Kidney Fund Clinical Scientist in Nephrology Program. Portions of these data were presented in abstract form at the annual meeting of the American Society of Nephrology; October 29 through November 1, 2004; St. Louis, MO; and the Pediatric Academic Society Meeting, May 14 to 17, 2005; Washington, DC. The data reported here were supplied by the Centers for Medicare & Medicaid Services ESRD Clinical Performance Measures Project and the USRDS. We thank Marjorie R. Bedinger, BA, for assistance in creating the data file for analysis. References 1. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 16: , Albers FJ: Causes of hemodialysis access failure. Adv Ren Replace Ther 1: , Caruana RJ, Raja RM, Zeit RM, Goldstein SJ, Kramer MS: Thrombotic complications of indwelling central catheters used for chronic hemodialysis. Am J Kidney Dis 9: , Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, et al.: Canadian Hemodialysis Morbidity Study. Am J Kidney Dis 19: , Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in US hemodialysis patients. Kidney Int 60: , Harland RC: Placement of permanent vascular access de-
6 992 Clinical Journal of the American Society of Nephrology Clin J Am Soc Nephrol 1: , 2006 vices: Surgical considerations. Adv Ren Replace Ther 1: , Hoen B, Paul-Dauphin A, Hestin D, Kessler M: EPIBAC- DIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 9: , Kairaitis LK, Gottlieb T: Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 14: , Kherlakian GM, Roedersheimer LR, Arbaugh JJ, Newmark KJ, King LR: Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg 152: , Munda R, First MR, Alexander JW, Linnemann CC Jr, Fidler JP, Kittur D: Polytetrafluoroethylene graft survival in hemodialysis. JAMA 249: , Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL: Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 202: , Pastan S, Soucie JM, McClellan WM: Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62: , Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 55: , Tokars JI, Miller ER, Stein G: New national surveillance system for hemodialysis-associated infections: Initial results. Am J Infect Control 30: , Centers for Medicare & Medicaid Services: Fistula First. National Vascular Access Improvement Initiative. Available: Accessed December 13, National Kidney Foundation: K/DOQI clinical practice guidelines for vascular access, Am J Kidney Dis 37: , United States Renal Data System: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Centers for Medicare & Medicaid Services: 2004 Annual Report, End Stage Renal Disease Clinical Performance Measures Project, Baltimore, Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards & Quality, December Frankenfield DL, Neu AM, Warady BA, Watkins SL, Friedman AL, Fivush BA: Adolescent hemodialysis: Results of the 2000 ESRD Clinical Performance Measures Project. Pediatr Nephrol 17: 10 15, Brittinger WD, Walker G, Twittenhoff WD, Konrad N: Vascular access for hemodialysis in children. Pediatr Nephrol 11: 87 95, Gradman WS, Lerner G, Mentser M, Rodriguez H, Kamil ES: Experience with autogenous arteriovenous access for hemodialysis in children and adolescents. Ann Vasc Surg 19: , Lumsden AB, MacDonald MJ, Allen RC, Dodson TF: Hemodialysis access in the pediatric patient population. Am J Surg 168: , Ramage IJ, Bailie A, Tyerman KS, McColl JH, Pollard SG, Fitzpatrick MM: Vascular access survival in children and young adults receiving long-term hemodialysis. Am J Kidney Dis 45: , Sheth RD, Brandt ML, Brewer ED, Nuchtern JG, Kale AS, Goldstein SL: Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Kidney Int 62: , Chand DH, Brier M, Strife CF: Comparison of vascular access type in pediatric hemodialysis patients with respect to urea clearance, anemia management, and serum albumin concentration. Am J Kidney Dis 45: , Goldstein SL, Macierowski CT, Jabs K: Hemodialysis catheter survival and complications in children and adolescents. Pediatr Nephrol 11: 74 77, Verrina E, Edefonti A, Gianoglio B, Rinaldi S, Sorino P, Zacchello G, Lavoratti G, Maringhini S, Pecoraro C, Calevo MG, Turrini Dertenois L, Perfumo F: A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol 19: 82 90, Frankenfield DL, Neu AM, Warady BA, Fivush BA, Johnson CA, Brem AS: Anemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project. Kidney Int 64: , Smith JM, McDonald RA: Renal transplantation in adolescents. Adolesc Med Clin 16: , Cecka JM, Gjertson DW, Terasaki PI: Pediatric renal transplantation: A review of the UNOS data. United Network for Organ Sharing. Pediatr Transplant 1: 55 64, Bagolan P, Spagnoli A, Ciprandi G, Picca S, Leozappa G, Nahom A, Trucchi A, Rizzoni G, Fabbrini G: A ten-year experience of Brescia-Cimino arteriovenous fistula in children: Technical evolution and refinements. J Vasc Surg 27: , Bourquelot P, Cussenot O, Corbi P, Pillion G, Gagnadoux MF, Bensman A, Loirat C, Broyer M: Microsurgical creation and follow-up of arteriovenous fistulae for chronic haemodialysis in children. Pediatr Nephrol 4: , Bourquelot P, Raynaud F, Pirozzi N: Microsurgery in children for creation of arteriovenous fistulas in renal and non-renal diseases. Ther Apher Dial 7: , Sanabia J, Polo JR, Morales MD, Canals MJ, Polo J, Serantes A: Microsurgery in gaining paediatric vascular access for haemodialysis. Microsurgery 14: , 1993
mean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).
S44 Figure 53 depicts the trend in Epoetin dosing from the 1998 study period to the 2003 study period, with an increasing mean weekly Epoetin dose (units/kg/wk) for patients prescribed Epoetin in lower
More informationOriginal Article Arteriovenous Access in Children Pak Armed Forces Med J 2016; 66(2): Nauman Imtiaz
Original Article Arteriovenous Access in Children Pak Armed Forces Med J 2016; 66(2):285-89 ARTERIOVENOUS ACCESS IN CHILDREN Nauman Imtiaz Combined Military Hospital Rawalpindi Pakistan ABSTRACT Objective:
More informationFinal published version:
Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: A retrospective cohort study Laura Plantinga, Emory University
More informationAJNT. Original Article
. 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin
More informationSerum Albumin Level and Risk for Mortality and Hospitalization in Adolescents on Hemodialysis
Serum Albumin Level and Risk for Mortality and Hospitalization in Adolescents on Hemodialysis Sandra Amaral,* Wenke Hwang, Barbara Fivush, Alicia Neu, Diane Frankenfield, and Susan Furth *Department of
More informationNoninvasive Interventions to Decrease Hospitalization and Associated Costs for Pediatric Patients Receiving Hemodialysis
J Am Soc Nephrol 14: 2127 2131, 2003 Noninvasive Interventions to Decrease Hospitalization and Associated Costs for Pediatric Patients Receiving Hemodialysis STUART L. GOLDSTEIN,* CAROLYN M. SMITH, and
More informationASDIN 7th Annual Scientific Meeting
Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of
More informationVascular Access Profile in Maintenance Hemodialysis Patients
DIALYSIS Vascular Access Profile in Maintenance Hemodialysis Anoop Gowda, 1 Malleshappa Pavan, 2 Kishore Babu 3 Original Paper 1 Division of Nephrology, Department of Medicine, Dr BR Ambedkar Medical College
More informationDedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments
http://www.kidney-international.org & 2006 International Society of Nephrology original article Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationHemodialysis vascular access options in pediatrics: considerations for patients and practitioners
Pediatr Nephrol (2009) 24:1121 1128 DOI 10.1007/s00467-008-0812-3 EDUCATIONAL REVIEW Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners Deepa H. Chand & Rudolph
More informationRACE AND SEX DISPARITIES IN
ORIGINAL CONTRIBUTION Impact of Quality Improvement Efforts on Race and Sex Disparities in Hemodialysis Ashwini R. Sehgal, MD RACE AND SEX DISPARITIES IN health outcomes have been extensively documented.
More informationPreservation of Veins and Timing for Vascular Access
Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access
More informationIN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006
IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE
More informationDifferences in intermediate outcomes for Asian and non-asian adult hemodialysis patients in the United States
Kidney International, Vol. 64 (2003), pp. 623 631 Differences in intermediate outcomes for Asian and non-asian adult hemodialysis patients in the United States DIANE L. FRANKENFIELD, SYLVIA P.B. RAMIREZ,
More informationLate Creation of Vascular Access for Hemodialysis and Increased Risk of Sepsis
J Am Soc Nephrol 15: 1936 1942, 2004 Late Creation of Vascular Access for Hemodialysis and Increased Risk of Sepsis MATTHEW J. OLIVER,* DEANNA M. ROTHWELL, KINWAH FUNG, JANET E. HUX,* and CHARMAINE E.
More informationMORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS
MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS, PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION, AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT
More information( GFR 30 ml/min/1.73m 2 ) [2] (Tunneled cuffed catheter) [1] [3]
[1] 07-3422121-2045 E-mail: cyhsu@vghks.gov.tw ( GFR 30 ml/min/1.73m 2 ) [2] (fistula) (graft) (Tunneled cuffed catheter) [3] 97 20 2 63 Allen s test (Duplex doppler ultrasound) [4] 2.0 mm2.5 mm [5] ()
More informationDialysis Dose and Body Mass Index Are Strongly Associated with Survival in Hemodialysis Patients
J Am Soc Nephrol 13: 1061 1066, 2002 Dialysis Dose and Body Mass Index Are Strongly Associated with Survival in Hemodialysis Patients FRIEDRICH K. PORT, VALARIE B. ASHBY, RAJNISH K. DHINGRA, ERIK C. ROYS,
More informationPredictors of adequacy of arteriovenous fistulas in hemodialysis patients
Kidney International, Vol. 56 (1999), pp. 275 280 Predictors of adequacy of arteriovenous fistulas in hemodialysis patients DIALYSIS TRANSPLANTATION PAUL E. MILLER, ASHITA TOLWANI, C. PETER LUSCY, MARK
More informationCATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care
CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your
More informationFULFILLMENT OF K/DOQI GUIDELINES 92 anemia treatment dialysis therapy vascular access
INTRODUCTION ANEMIA TREATMENT hemoglobin levels epo treatment iron treatment FULFILLMENT OF K/DOQI GUIDELINES 2 anemia treatment dialysis therapy vascular access EPO DOSING PATTERNS 4 epo dosing per kg
More informationThe mortality rate of treated patients with ESRD was 23
Early Intervention Improves Mortality and Hospitalization Rates in Incident Hemodialysis Patients: RightStart Program Rebecca L. Wingard,* Lara B. Pupim, Mahesh Krishnan, Ayumi Shintani, T. Alp Ikizler,
More informationDialysis Event Protocol
Dialysis Event Protocol Introduction In 2009, more than 370,000 patients were treated with maintenance hemodialysis in the United States. 1 Hemodialysis patients require a vascular access, which can be
More informationExperience with Arteriovenous Fistulas for Chronic Hemodialysis in Pediatric Age Group. Nehad Zaid
Experience with Arteriovenous Fistulas for Chronic Hemodialysis in Pediatric Age Group Nehad Zaid Vascular Surgery Unit, General Surgery Department, Menoufiya University Hospitals nehadzaid@yahoo.com Abstract:
More informationLesson #7: Quality Assessment and Performance Improvement
ESRD Update: Transitioning to New ESRD Conditions for Coverage Student Manual Lesson #7: Quality Assessment and Performance Improvement Learning Objectives At the conclusion of this lesson, you will be
More informationconsiderable economic impact, with the estimated total
Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity
More informationNATIONAL QUALITY FORUM Renal EM Submitted Measures
NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB
More informationIN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators
IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following
More informationArteriovenous Graft Infection: A Comparison of Thigh and Upper Extremity Grafts
CJASN epress. Published on June 16, 2011 as doi: 10.2215/CJN.00490111 Article Arteriovenous Graft Infection: A Comparison of Thigh and Upper Extremity Grafts Abha Harish and Michael Allon Summary Background
More informationVascular Access creation in the US A surgical perspective. Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery
Vascular Access creation in the US A surgical perspective Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery Disclosures No specific disclosures pertaining to the topic of presentation
More informationTRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA
& TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia
More informationType of vascular access and mortality in U.S. hemodialysis patients
Kidney International, Vol. 60 (2001), pp. 1443 1451 Type of vascular access and mortality in U.S. hemodialysis patients RAJNISH K. DHINGRA, ERIC W. YOUNG, T.E. HULBERT-SHEARON, SEAN F. LEAVEY, and FRIEDRICH
More informationRegional variability in anaemia management and haemoglobin in the US
Nephrol Dial Transplant (2003) 18: 147 152 Original Article Regional variability in anaemia management and haemoglobin in the US Donal N. Reddan 1, Diane L. Frankenfield 2, Preston S. Klassen 1, Joseph
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 8: Pediatric ESRD 1,462 children in the United States began end-stage renal disease (ESRD) care in 2013. 9,921 children were being treated for ESRD on December
More informationTechnical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University
More informationIncident Hemodialysis
The Acute Kidney Injury Group Modifying the Highest Mortality Rate in the Major AKI Adverse Outcome Other than Death: Loss ESRD & Incident Hemodialysis The EVA QI Program Integrated Inpatient Early Vascular
More information2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611
Healthy People 2020 In this chapter, we examine data for 11 Healthy People 2020 (HP2020) objectives 10 for CKD and one for diabetes spanning 20 total indicators for which the USRDS serves as the official
More informationRenal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)
More informationRecombinant human erythropoietin (EPO) is an effective
Septicemia in Patients with ESRD Is Associated with Decreased Hematocrit and Increased Use of Erythropoietin Allen R. Nissenson,* Michelle L. Dylan, Robert I. Griffiths, Hsing-Ting Yu, and Robert W. Dubois
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationState Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE
Dear State Surveyor: State Profile for FY 2018 for Dialysis Patients and Facilities - STATE SAMPLE This report is designed to provide a comparative summary of treatment patterns and patient outcomes for
More informationChapter 8: ESRD Among Children, Adolescents, and Young Adults
Chapter 8: ESRD Among Children, Adolescents, and Young Adults The number of children beginning end-stage renal disease (ESRD) care decreased by 6% in 2014, totaling 1,398 (Figure 8.1.a). 9,721 children
More informationDecreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program
Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients
More informationClinical Performance Measures for ESRD Patients. Lana Kacherova, QI Director, ESRD Network th Annual NANT Symposium February 12, 2009
Clinical Performance Measures for ESRD Patients Lana Kacherova, QI Director, ESRD Network 18 26 th Annual NANT Symposium February 12, 2009 Health Care Quality Improvement Program (HCQIP) The Center for
More informationIn long-term hemodialysis (HD) patients, an arteriovenous
Change in Vascular Access and Hospitalization Risk in Long-Term Hemodialysis Patients Eduardo Lacson, Jr., Weiling Wang, J. Michael Lazarus, and Raymond M. Hakim Fresenius Medical Care, North America,
More informationIncreased risk of death in African American patients with end-stage renal disease secondary to lupus
Clin Kidney J (2014) 7: 40 44 doi: 10.1093/ckj/sft157 Advance Access publication 2 January 2014 Original Article Increased risk of death in patients with end-stage renal disease secondary to lupus Sangeeta
More informationEvaluation and management of nutrition in children
Evaluation and management of nutrition in children Date written: May 2004 Final submission: January 2005 Author: Elisabeth Hodson GUIDELINES No recommendations possible based on Level I or II evidence
More informationChapter Five Clinical indicators & preventive health
Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being
More informationChapter six Outcomes: hospitalization & mortality. There is an element of death in life, and I am astonished
INTRODUCTION 1 OVERALL HOSPITALIZATION & MORTALITY 1 hospital admissions & days, by primary diagnosis & patient vintage five-year survival mortality rates, by patient vintage expected remaining lifetimes
More informationFOUR. Clinical Indicators of Care
Clinical Indicators of Care T FOUR The great questions of the time are not decided by speeches and majority decisions but by iron and blood. Otto von Bismarck, Speech to the Prussian Diet 78 ž 2000 ATLAS
More informationChapter 7: ESRD among Children, Adolescents, and Young Adults
Chapter 7: ESRD among Children, Adolescents, and Young Adults The one-year end-stage renal disease (ESRD) patient mortality among the 0-4 year age group has declined approximately 41.6% over the past decade.
More informationDialysis Adequacy (HD) Guidelines
Dialysis Adequacy (HD) Guidelines Peter Kerr, Convenor (Monash, Victoria) Vlado Perkovic (Camperdown, New South Wales) Jim Petrie (Woolloongabba, Queensland) John Agar (Geelong, Victoria) Alex Disney (Woodville,
More informationSid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face
Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National
More informationMIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai
MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa,
More informationIncreased Hemodialysis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Registry
Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Registry 2001 2004 Louise M. Moist,* Lilyanna Trpeski, Yingbo Na, and Charmaine E.
More informationRisk factors for increased variability in dialysis delivery in haemodialysis patients
Nephrol Dial Transplant (2003) 18: 2112 2117 DOI: 10.1093/ndt/gfg297 Original Article Risk factors for increased variability in dialysis delivery in haemodialysis patients K. Scott Brimble, Darin J. Treleaven,
More informationASDIN 8th Annual Scientific Meeting
Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure
More informationDr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley
Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley Approximately 45% of AVF are functional without intervention after creation The procedure rate is 1.45-3.3 procedures/avf
More informationRegardless of whether you are a vascular surgeon,
C A S E R E P O R T The Versatility of the GORE VIABAHN Endoprosthesis Several case reports highlighting its unique design and why it is a valuable tool for the interventionist. BY PETER WAYNE, MD Regardless
More informationDeveloping a Quality Assurance Performance Improvement (QAPI) Program at Your Dialysis Center Rudolph P. Valentini, M.D. Associate Professor of Pediatrics Director of Dialysis Services Vice Chief of Staff
More informationClinical Performance Goals
Clinical Performance Goals 2011-2012 Clinical Performance Goals 2011-2012 Table of Contents Table of Contents... 1 Health Care Quality Improvement Program... 2 Clinical Performance Measures... 6 Chapter
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 10: Dialysis Providers In 2013, collectively the three large dialysis organizations treated 71% of patients in 67% of all dialysis units. In the Small Dialysis
More informationVascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?
Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier? Plan the Work Work the Plan What is a plan? A method for achieving an end An orderly arrangement of parts
More informationMedical Director/Surgeon as Partners WebEx February 11, 2010
Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances
More informationStaff-Assisted Home Hemodialysis
Medical Coverage Policy Staff-Assisted Home Hemodialysis Table of Contents Coverage Policy... 1 Overview... 1 General Background... 2 Coding/Billing Information... 4 References... 4 Effective Date...11/15/2017
More informationCardiovascular Comorbidity and Late Referral Impact Arteriovenous Fistula Survival: A Prospective Multicenter Study
J Am Soc Nephrol 15: 204 209, 2004 Cardiovascular Comorbidity and Late Referral Impact Arteriovenous Fistula Survival: A Prospective Multicenter Study PIETRO RAVANI,* GIULIANO BRUNORI, SALVATORE MANDOLFO,
More informationRisk Factors Associated with Patency Loss of Hemodialysis Vascular Access within 6 Months
Risk Factors Associated with Patency Loss of Hemodialysis Vascular Access within 6 Months Mauricio Monroy-Cuadros,* Serdar Yilmaz,* Anastasio Salazar-Bañuelos,* and Christopher Doig *Division of Transplantation,
More informationStatus of the CKD and ESRD treatment: Growth, Care, Disparities
Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator
More informationIntroduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents
Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce
More informationThe LifeSite Hemodialysis Access System in patients with limited access
From the Society for Clinical Vascular Surgery The LifeSite Hemodialysis Access System in patients with limited access Sunil S. Rayan, MD, Thomas T. Terramani, MD, Victor J. Weiss, MD, and Elliot L. Chaikof,
More informationJuxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?
Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Richard Shoenfeld MD, FSIR, FAHA The Access Center at West Orange West Orange, New Jersey USA SEDAV 2015 Madrid November
More informationRole of Covered Stents and Drug Eluting Balloons In Dialysis Access
Role of Covered Stents and Drug Eluting Balloons In Dialysis Access Joseph Habib, MD, FACS Assistant Professor Department of Surgery Division of Vascular and Endovascular Surgery University of Florida
More informationReviews in Infection
Reviews in Infection RIF 1(1):1-6 (2010) RIF ISSN:1837-6746 Original Research Infection related processes during haemodialysis: A study in General Hospital Haemodialysis unit Naser Hussain 1, *Mona F.
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationMortality for dialysis patients is highest during the
The Right of Passage: Surviving the First Year of Dialysis Rebecca L. Wingard, Kevin E. Chan, J. Michael Lazarus, and Raymond M. Hakim Fresenius Medical Care North America, Waltham, Massachusetts Mortality
More informationCurrent treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database
ORIGINAL ARTICLE Korean J Intern Med 218;33:116-1168 https://doi.org/1.394/kjim.218.17 Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health
More informationImprovement in Pittsburgh Symptom Score Index After Initiation of Peritoneal Dialysis
Advances in Peritoneal Dialysis, Vol. 24, 2008 Matthew J. Novak, 1 Heena Sheth, 2 Filitsa H. Bender, 1 Linda Fried, 1,3 Beth Piraino 1 Improvement in Pittsburgh Symptom Score Index After Initiation of
More informationTREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009
TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December
More informationRCSIsmjoriginal article
The effect of optimising clinical performance measures on outcomes in haemodialysis patients Amy Bagatto 1, Nalayeni Errakiah 1, Mathan Munusamy 1, Rory McQuillan 2, Peter Conlon 2 1 RCSI medical student
More informationEffects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes
Original Investigation Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson Jr, MD, MPH, Weiling Wang, MS, Cari DeVries, Keith
More informationChapter 3: Vascular Access
Chapter 3: Vascular Access In 2016, 80% of patients were using a catheter at hemodialysis (HD) initiation (Figure 3.1). At 90 days after the initiation of HD, 69% of patients were still using catheters.
More informationAssociation between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
Nephrol Dial Transplant (2008) 23: 1682 1689 doi: 10.1093/ndt/gfm845 Advanced Access publication 8 December 2007 Original Article Association between number of months below K/DOQI haemoglobin target and
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationChapter 10: Dialysis Providers
Chapter 10: Dialysis Providers In 2014 the two largest dialysis organizations, Fresenius and DaVita, collectively treated 69% of patients in 65% of all dialysis units (Figure 10.2). Nearly 90% of all dialysis
More informationLong-term outcomes in nondiabetic chronic kidney disease
original article http://www.kidney-international.org & 28 International Society of Nephrology Long-term outcomes in nondiabetic chronic kidney disease V Menon 1, X Wang 2, MJ Sarnak 1, LH Hunsicker 3,
More information2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE
Purpose of the Report Enclosed is the (DFR) for your facility, based on data from the Centers for Medicare & Medicaid Services (CMS). This DFR includes data specific to CCN(s): 999999 These data could
More informationESRD Analytical Methods Contents
ESRD Analytical Methods Contents Volume 2: ESRD Analytical Methods... 227 Introduction... 230 Data Sources... 230 Consolidated Renal Operations in a Web-enabled Network... 230 CMS Medicare Enrollment Database...
More informationThe vexing problem of suboptimal initiation of dialysis: Can we do better?
Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,
More informationChapter 2: Identification and Care of Patients with CKD
Chapter 2: Identification and Care of Patients with CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease
More informationDifference in practical dialysis therapy between East Asia and US/EU
Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society
More informationJVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE
JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,
More informationApril 18, Dear Mr. Blum and Dr. Conway:
April 18, 2014 Dear Mr. Blum and Dr. Conway: On behalf of the undersigned patient and health professional organizations, thank you for meeting with us Wednesday, September 18, 2013. Our organizations were
More informationSupplementary Online Content
Supplementary Online Content Swaminathan S, Sommers BD,Thorsness R, Mehrotra R, Lee Y, Trivedi AN. Association of Medicaid expansion with 1-year mortality among patients with end-stage renal disease. JAMA.
More informationChapter 2: Identification and Care of Patients With CKD
Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,
More informationINTEGRATED CARE. Table 1. RVCARE core components and goals. Figure 2. Patients who choose PD in the RVCARE Program
The first 120 days of crucial care: Strategies for managing incident dialysis patients Naveena Reddy, MS, RD Farzeen Sukheswalla, MS, RD George R. Aronoff, MD, MS, FACP. The Renal ACO New Approaches to
More informationMeasure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care
Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is
More information